Article
Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension.
Pharmacogenetics and genomics - 1 Jan 2005
King Lorraine M, Gainer James V, David Gloria L, Dai Ding, Goldstein Joyce A, Brown Nancy J, Zeldin Darryl C
Abstract excerpt
CYP2J2 and CYP2C8 metabolize arachidonic acid (AA) to cis-epoxyeicosatrienoic acids (EETs), which play a central role in regulating renal tubular fluid-electrolyte transport and vascular tone. We hypothesized that functionally relevant polymorphisms in the CYP2J2 or CYP2C8 genes influence hypertension risk. We examined associations between CYP2J2*7 (G-50 T promoter) and CYP2C8*3 (Arg139Lys and Lys399Arg, which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
